Influence of silencing TRAF6 with shRNA on LPS/TLR4 signaling in vitro

Abstract

This study investigated the influence of silencing TRAF6 with shRNA on lipopolysaccharide (LPS)/toll-like receptor (TLR)-4 signaling pathway in vitro. Four plasmids (pGCsi-TRAF6-shRNA1, 2, 3, 4) containing different shRNA sequences were designed and synthesized. The proliferation of RAW264.7 cells after transfected with these plasmids was measured by MTT assay. Inflammatory cellular models were established by LPS stimulation. Levels of TNF-α, IL-1β and TGF-β1 in the supernatants, mRNA expressions of TRAF6, IL-6 and COX-2, protein expression of TRAF6 and translocation of NF-κB were assayed by ELISA, real-time quantitative PCR and Western blotting, respectively. The results showed that the TRAF6 gene knockdown by RNAi hardly inhibited the proliferation of RAW264.7 cells within 72 h. The mRNA and protein expression of TRAF6 was lower in the TRAF6-shRNA1, 2 groups than in the TRAF6-shRNA3, 4 groups. Therefore, pGCsi-TRAF6-shRNA1, 2 were selected for the subsequent experiments. Our results still showed that pGCsi-TRAF6-shRNA1, 2 could significantly reduce the production of pro-inflammatory cytokines and mediators including TNF-α, IL-1β, IL-6 and COX-2, and inhibit NF-κB nuclear translocation. Moreover, pGCsi-TRAF6-shRNA1, 2 could suppress the release of TGF-β1 at the protein level. It was concluded that the recombinant plasmid pTRAF6-shRNA can, to some extent, inhibit inflammatory response stimulated by LPS at the initial phase. TRAF6 may become the potential therapeutic target of many inflammation-related diseases.

Keywords

tumor necrosis factor receptor-associated factor-6 / RNA interference / lipopolysaccharide / Toll-like receptor 4 signaling / nuclear factor kappa B

References

[1] DoyleS.L., O’NeillL.A.. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol, 2006, 72(9): 1102-1113

[2] WuH., ArronJ.R.. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays, 2003, 25(11): 1096-1105

[3] AsagiriM., TakayanagiH.. The molecular understanding of osteoclast differentiation. Bone, 2007, 40(2): 251-264

[4] KimK.M., KwonY.G., ChungH.T., et al.. Methanol extract of cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol Appl Pharmacol, 2003, 190(1): 1-8

[5] FengC., ShengS.H., RongY.Q., et al.. Construction and expression of mouse TRAF6-shRNA expression plasmid. World Chin J Digestol (Chinese), 2009, 17(14): 1406-1411

[6] LivakK.J., SchmittgenT.D.. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods, 2001, 25(4): 402-408

[7] HwangT.H., YoonB.C., JeongJ.S., et al.. A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure. Life Sci, 2003, 72(7): 851-861

[8] QiuL., SongL., YuY., et al.. Identification and expression of TRAF6 (TNF receptor-associated factor 6) gene in Zhikong Scallop Chlamys farreri. Fish Shellfish Immunol, 2009, 26(3): 359-367

[9] BelladonnaM.L., VaccaC., VolpiC., et al.. IL-23 neutralization protects mice from gram-negative endotoxic shock. Cytokine, 2006, 34(3–4): 161-169

[10] KobayashiT., WalshM.C., ChoiY.. The role of TRAF6 in signal transduction and the immune response. Microbes Infect, 2004, 6(14): 1333-1338

[11] LoniewskiK.J., PatialS., ParameswaranN.. Sensitivity of TLR4-and-7-induced NF-κB1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Mol Immunol, 2007, 44(15): 3715-3723

[12] YangY.J., ChenW., CarriganS.O., et al.. TRAF6 specifically contributes to Fcepsilon RI-mediated cytokine production but not mast cell degranulation. J Biol Chem, 2008, 283(46): 32110-32118

[13] MachadoF.S., EsperL., DiasA., et al.. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. J Exp Med, 2009, 206(11): 2573

[14] LomagaM.A., HendersonJ.T., EliaA.J., et al.. TNF receptor-associated factor-6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS. J Neurosci, 2000, 20(19): 7384-7393

[15] TianX., ZhangP., Zamek-GliszczynskiM.J., et al.. Knocking down transport: applications of RNA interference in the study of drug transport proteins. Drug Metab Rev, 2005, 37(4): 705-723

[16] GeorgeJ., TsutsumiM.. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther, 2007, 14(10): 790-803

[17] SongE., LeeS.K., WangJ., et al.. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 2003, 9(3): 347-351

[18] KimK.H., KimH.C., HwangM.Y., et al.. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun, 2006, 343(4): 1072-1078

[19] SchwabeR.F., BrennerD.A.. Mechanisms of liver injury I. TNF-alpha induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointes Liver Physiol, 2006, 290(4): G583-589

[20] HuynhM.L., FadokV.A., HensonP.M.. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest, 2002, 109(1): 41-50

[21] OtsukaM., NegishiY., AramakiY.. Involvement of phosphatidylinositol-3-kinase and ERK pathways in the production of TGF-β1 by macrophages treated with liposomes composed of phosphatidylserine. FEBS Lett, 2007, 581(2): 325-330

[22] ViatourP., MervilleM.P., BoursV., et al.. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci, 2005, 30(1): 43-52

[23] BrasierA.R.. The NF-kappaB regulatory network. Cardiovasc Toxicol, 2006, 6(2): 111-130

[24] AggarwalB.B., ShishodiaS., SandurS.K., et al.. Inflammation and cancer: how hot is the link?. Biochem Pharmacol, 2006, 72(11): 1605-1621

[25] TsatsanisC., AndroulidakiA., VenihakiM., et al.. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol, 2006, 38(10): 1654-166